ClinVar Miner

Submissions for variant NM_000053.4(ATP7B):c.1745_1746del (p.Ile582fs) (rs753962912)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000169524 SCV000221001 likely pathogenic Wilson disease 2014-12-31 criteria provided, single submitter literature only
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000726071 SCV000341737 pathogenic not provided 2016-04-28 criteria provided, single submitter clinical testing
Invitae RCV000169524 SCV000931649 pathogenic Wilson disease 2018-09-12 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ile582Argfs*25) in the ATP7B gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs753962912, ExAC 0.004%). This variant has been observed in individuals affected with Wilsons disease (PMID: 23518715, 17317524, 27398169, 17949296). ClinVar contains an entry for this variant (Variation ID: 189112). Loss-of-function variants in ATP7B are known to be pathogenic (PMID: 10441329, 16283883). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.